Treatment of HCV with direct-acting antivirals on reducing mortality related to extrahepatic manifestations: a large population-based study in British Columbia, CanadaResearch in context

• Main Authors: Dahn Jeong (Author), Stanley Wong (Author), Mohammad Ehsanul Karim (Author), Amee R. Manges (Author), Jean Damascene Makuza (Author), Sofia R. Bartlett (Author), Héctor Alexander Velásquez García (Author), Daryl Luster (Author), Prince Asumadu Adu (Author), Mawuena Binka (Author), Amanda Yu (Author), Mel Krajden (Author), Naveed Zafar Janjua (Author)
• Format: Book
• Published: Elsevier, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: HCV infection is associated with mortality due to extrahepatic manifestations (EHM). Sustained virologic response (SVR) following direct-acting antiviral (DAA) therapy has been linked to decreased all-cause and liver-related mortality. However, evidence regarding the impact of D...